Betulinic acid suppresses carcinogen-induced NF-κB activation through inhibition of IκBα kinase and p65 phosphorylation: Abrogation of cyclooxygenase-2 and matrix metalloprotease-9

Journal of Immunology

Volumn 171, Issue 6, 2003, Pages 3278-3286

  Takada, Yasunari ^a   Aggarwal, Bharat B ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETULIC ACID; CIGARETTE SMOKE; CYCLOOXYGENASE 2; GELATINASE B; HYDROGEN PEROXIDE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; OKADAIC ACID; SYNAPTOTAGMIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR 1;

ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CARCINOGENICITY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INDUCTION; ENZYME INHIBITION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOMODULATION; INHIBITION KINETICS; MODULATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; REPORTER GENE; WESTERN BLOTTING;

EID: 0042834196     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.6.3278     Document Type: Article

References (60)

1. Pisha. E., H. Chai, I. S. Lee, T. E. Chagwedera, N. R. Farnsworth, G. A. Cordell, C. W. Beecher, H. H. Fong, A. D. Kinghorn, D. M. Brown, et al. 1995. Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis. Nat. Med. 1:1046.
2. Selzer, E., E. Pimentel, V. Wacheck, W. Schlegel, H. Pehamberger, B. Jansen. and R. Kodym. 2000. Effects of betulinic acid alone and in combination with irradiation in human melanoma cells. J. Invest. Dermatol. 114:935.
3. Schmidt, M. L., K. L. Kuzmanoff, L. Ling-Indeck, and J. M. Pezzuto. 1997. Betulinic acid induces apoptosis in human neuroblastoma cell lines. Eur. J. Cancer 33:2007.
4. Fulda, S., I. Jeremias, H. H. Steiner, T. Pietsch, and K. M. Debatin. 1999. Betulinic acid: a new cytotoxic agent against malignant brain-tumor cells. Int. J. Cancer 82:435.
5. Wick, W., C. Grimmel, B. Wagenknecht, J. Dichgans, and M. Weller. 1999. Betulinic acid-induced apoptosis in glioma cells: a sequential requirement for new protein synthesis, formation of reactive oxygen species, and caspase processing. J. Pharmacol. Exp. Ther. 289:1306.
6. Fulda, S., C. Friesen, M. Los, C. Scaffidi, W. Mier, M. Benedict, G. Nunez, P. H. Krammer, M. E. Peter, and K. M. Debatin. 1997. Betulinic acid triggers CD95 (APO-1/Fas)- and p53-independent apoptosis via activation of caspases in neuroectodermal tumors. Cancer Res. 57:4956.
7. Fulda, S., S. A. Susin, G. Kroemer, and K. M. Debatin. 1998. Molecular ordering of apoptosis induced by anticancer drugs in neuroblastoma cells. Cancer Res. 58:4453.
8. Salti, G. I., J. V. Kichina, T. K. Das Gupta, S. Uddin, L. Bratescu, J. M. Pezzuto, R. G. Mehta, and A. I. Constantinou. 2001. Betulinic acid reduces ultraviolet-C-induced DNA breakage in congenital melanocytic naeval cells: evidence for a potential role as a chemopreventive agent. Melonoma Res. 11:99.
9. Evers, M., C. Poujade, F. Soler, Y. Ribeill, C. James, Y. Lelievre, J. C. Gueguen, D. Reisdorf, I. Morize, R. Pauwels, et al. 1996. Betulinic acid derivatives: a new class of human immunodeficiency virus type 1 specific inhibitors with a new mode of action. J. Med. Chem. 39:1056.
10. Kashiwada, Y., F. Hashimoto, L. M. Cosentino, C. H. Chen, P. E. Garrett, and K. H. Lee. 1996. Betulinic acid and dihydrobetulinic acid derivatives as potent anti-HIV agents. J. Med. Chem. 39:1016.
11. Soler, F., C. Poujade, M. Evers, J. C. Carry, Y. Henin, A. Bousseau, T. Huet, R. Pauwels, E. De Clercq, J. F. Mayaux, et al. 1996. Betulinic acid derivatives: a new class of specific inhibitors of human immunodeficiency virus type 1 entry. J. Med. Chem. 39:1069.
12. Mukherjee, P. K., K. Saha, J. Das, M. Pal. and B. P. Saha. 1997. Studies on the anti-inflammatory activity of rhizomes of Nelumbo nucifera. Planta Med. 63:367.
13. Recio, M. C., R. M. Giner. S. Manez, J. Gueho. H. R. Julien. K. Hostettmann, and J. L. Rios. 1995. Investigations on the steroidal anti-inflammatory activity of triterpenoids from Diospyros leucomelas. Planta Med. 61:9.
14. Kelloff. G. J. 2000. Perspectives on cancer chemoprevention research and drug development. Adv. Cancer Rev. 78:199.
15. Aggarwal, B. B. 2000. Tumour necrosis factors receptor associated signalling molecules and their role in activation of apoptosis, JNK and NF-κB. Ann. Rheum. Dis. 59(Suppl. 1):i6.
16. Komori, A., J. Yatsunami, M. Suganuma, S. Okabe, S. Abe. A. Sakai, K. Sasaki, and H. Fujiki. 1993. Tumor necrosis factor acts as a tumor promoter in BALB/3T3 cell transformation. Cancer Res. 53:1982.
17. Suganuma, M., S. Okabe, M. W. Marino, A. Sakai, E. Sueoka, and H. Fujiki. 1999. Essential role of tumor necrosis factor α (TNF-α) in tumor promotion as revealed by TNF-α-deficient mice. Cancer Res. 59:4516.
18. Orosz, P., B. Echtenacher, W. Falk, J. Ruschoff, D. Weber, and D. N. Mannel. 1993. Enhancement of experimental metastasis by tumor necrosis factor. J. Exp. Med. 177:1391.
19. Hafner, M., P. Orosz, A. Kruger, and D. N. Mannel. 1996. TNF promotes metastasis by impairing natural killer cell activity. Int. J. Cancer 66:388.
20. Orosz, P., A. Kruger, M. Hubbe, J. Ruschoff, P. Von Hoegen, and D. N. Mannel. 1995. Promotion of experimental liver metastasis by tumor necrosis factor. Int. J. Cancer 60:867.
21. Moore, R. J., D. M. Owens, G. Stamp, C. Arnott, F. Burke, N. East, H. Holdsworth, L. Turner, B. Rollins, M. Pasparakis, et al. 1999. Mice deficient in tumor necrosis factor-α are resistant to skin carcinogenesis. Nat. Med. 5:828.
22. Giri, D. K., and B. B. Aggarwal. 1998. Constitutive activation of NF-κB causes resistance to apoptosis in human cutaneous T cell lymphoma HuT-78 cells. Autocrine role of tumor necrosis factor and reactive oxygen intermediates. J. Biol. Chem. 273:14008.
23. Aggarwal, B. B., L. Schwarz, M. E. Hogan, and R. F. Rando. 1996. Triple helix-forming oligodeoxyribonucleotides targeted to the human tumor necrosis factor (TNF) gene inhibit TNF production and block the TNF-dependent growth of human glioblastoma tumor cells. Cancer Res. 56:5156.
24. Arnott, C. H., K. A. Scott, R. J. Moore, A. Hewer, D. H. Phillips, P. Parker, F. R. Balkwill, and D. M. Owens. 2002. Tumour necrosis factor-α mediates tumour promotion via a PKC α- and AP-1-dependent pathway. Oncogene 21:4728.
25. Hehlgans, T., B. Stoelcker, P. Stopfer, P. Muller, G. Cemaianu, M. Guba, M. Steinbauer, S. A. Nedospasov, K. Pfeffer, and D. N. Mannel. 2002. Lymphotoxin-β receptor immune interaction promotes tumor growth by inducing angiogenesis. Cancer Res. 62:4034.
26. Suganuma, M., S. Okabe, M. Kurusu, N. lida, S. Ohshima, Y. Saeki, T. Kishimoto, and H. Fujiki. 2002. Discrete roles of cytokines, TNF-α, IL-1, IL-6 in tumor promotion and cell transformation. Int. J. Oncol. 20:131.
27. Sueoka, N., E. Sueoka, S. Okabe, and H. Fujiki. 1996. Anti-cancer effects of morphine through inhibition of tumour necrosis factor-α release and mRNA expression. Carcinogenesis 17:2337.
28. Suganuma, M., S. Okabe, E. Sueoka, N. lida, A. Komori, S. J. Kim, and H. Fujiki. 1996. A new process of cancer prevention mediated through inhibition of tumor necrosis factor α expression. Cancer Res. 56:3711.
29. Ghosh, S., M. J. May, and E. B. Kopp. 1998. NF-κB and Ret proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16:225.
30. Ghosh, S., and M. Karin. 2002. Missing pieces in the NF-κB puzzle, Cell 109(Suppl):S81.
31. Sizemore, N., N. Lemer, N. Dombrowski, H. Sakurai, and G. R. Stark. 2002. Distinct roles of the IκB kinase α and β subunits in liberating nuclear factor κB (NF-κB) from IκB and in phosphorylating the p65 subunit of NF-κB. J. Biol. Chem. 277:3863.
32. Wang, D., S. D. Westerheide, J. L. Hanson, and A. S. Baldwin, Jr. 2000. Tumor necrosis factor α-induced phosphorylation of RelA/p65 on Ser529 is controlled by casein kinase II. J. Biol. Chem. 275:32592.
33. Pahl, H. L. 1999. Activators and target genes of Rel/NF-κB transcription factors. Oncogene 18:6853.
34. Garg, A., and B. B. Aggarwal. 2002. Nuclear transcription factor-κB as a target for cancer drug development. Leukemia 16:1053.
35. Banerjee, S., C. Bueso-Ramos, and B. B. Aggarwal. 2002. Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-κB, cyclooxygenase 2, and matrix metalloprotease 9. Cancer Res. 62:4945.
36. Sporn, M. B., and N. Suh. 2002. Chemoprevention: an essential approach to controlling cancer. Nat. Rev. Cancer. 2:537.
37. Sporn, M. B., and N. Suh. 2000. Chemoprevention of cancer. Carcinogenesis 21:525.
38. Wattenberg, L. W. 1990. Inhibition of carcinogenesis by naturally-occurring and synthetic compounds. Basic Life Sci. 52:155.
39. Bharti, A. C., and B. B. Aggarwal. 2002. Chemopreventive agents induce suppression of nuclear factor-κB leading to chemosensitization. Ann. NY Acad. Sci. 973:392.
40. Ashikawa, K., S. Majumdar, S. Banerjee, A. C. Bharti, S. Shishodia, and B. Aggarwal. 2002. Piceatannol inhibits TNF-induced NF-κB activation and NF-κB-mediated gene expression through suppression of IκBα kinase and p65 phosphorylation. J. Immunol. 169:6490.
41. Chaturvedi, M. M., A. Mukhopadhyay, and B. B. Aggarwal. 2000. Assay for redox-sensitive transcription factor. Methods Enzymol. 319:585.
42. Majumdar, S., and B. B. Aggarwal. 2001. Methotrexate suppresses NF-κB activation through inhibition of IκBα phosphorylation and degradation, J. Immunol 167:2911.
43. Manna, S. K., A. Mukhopadhyay, and B. B. Aggarwal. 2000. IFN-α suppresses activation of nuclear transcription factors NF-KB and activator protein 1 and potentiates TNF-induced apoptosis. J. Immunol. 165:4927.
44. 2-terminal kinase. Cancer Res. 60:3838.
45. Bharti, A. C., N. Donato, S. Singh, and B. B. Aggarwal. 2003. Curcumin (diferuloylmethane) downregulates the constitutive activation of nuclear factor-κB and IκBα kinase in human multiple myeloma cells leading to suppression of proliferation and induction of apoptosis. Blood 101:1053.
46. Chaturvedi, M. M., R. LaPushin. and B. B. Aggarwal. 1994. Tumor necrosis factor and lymphotoxin. Qualitative and quantitative differences in the mediation of early and late cellular response. J. Biol. Chem. 269:14575.
47. Bonizzi, G., J. Piette, M. P. Merville, and V. Bours. 1997. Distinct signal transduction pathways mediate nuclear factor-κB induction by IL-1β in epithelial and lymphoid cells. J. Immunol. 159:5264.
48. Nasuhara, Y., I. M. Adcock, M. Catley, P. J. Bames, and R. Newton. 1999. Differential IκB kinase activation and IκBα degradation by interleukin-1β and tumor necrosis factor-α in human U937 monocytic cells: evidence for additional regulatory steps in κB-dependent transcription. J. Biol. Chem. 274:19965.
49. Simeonidis, S., D. Stauber, G. Chen, W. A. Hendrickson, and D. Thanos. 1999. Mechanisms by which IKB proteins control NF-κB activity. Proc. Natl. Acad. Sci. USA 96:49.
50. Hsu, H., H. B. Shu, M. G. Pan. and D. V. Goeddel. 1996. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84:299.
51. Plummer, S. M., K. A. Holloway, M. M. Manson, R. J. Munks, A. Kaptein, S. Farrow, and L. Howells. 1999. Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-κB activation via the NIK/IKK signalling complex. Oncogene 18:6013.
52. Verma, I. M., and J. Stevenson. 1997. IKB kinase: beginning, not the end. Proc. Natl. Acad. Sci. USA 94:11758.
53. Mayo, M. W., C. Y. Wang, P. C. Cogswell, K. S. Rogers-Graham, S. W. Lowe, C. J. Der, and A. S. Baldwin, Jr. 1997. Requirement of NF-κB activation to suppress p53-independent apoptosis induced by oncogenic Ras. Science 278:1812.
54. Pomerantz. J. L., and D. Baltimore. 2000. Signal transduction: a cellular rescue team. Nature 406:26.
55. Stancovski, I., and D. Baltimore. 1997. NF-κB activation: the IκB kinase revealed? Cell 91:299.
56. Maniatis, T. 1997. Catalysis by a multiprotein IκB kinase complex. Science 278:818.
57. Siebenlist, U., G. Franzoso, and K. Brown. 1994. Structure, regulation and function of NF-κB. Annu. Rev. Cell Biol. 10:405.
58. Verma, I. M., J. K. Stevenson, E. M. Schwarz, D. Van Antwerp, and S. Miyamoto. 1995. Rel/NF-κB/IκB family: intimate tales of association and dissociation. Genes Dev. 9:2723.
59. Yang, J., and A. Richmond. 2001. Constitutive IκB kinase activity correlates with nuclear factor-κB activation in human melanoma cells. Cancer Rev. 61:4901.
60. Nagai, S., K. Washiyama, M. Kurimoto, A. Takaku, S. Endo, and T. Kumanishi. 2002. Aberrant nuclear factor-κB activity and its participation in the growth of human malignant astrocytoma. J. Neurosurg. 96:909.